title: [Pharmacological and clinical profile of nitisinone (Orfadin(®) Capsules): a therapeutic agent for hereditary tyrosinemia type 1].
authors.forename: Hideaki
authors.initials: H
authors.lastname: Minoura
authors.forename: Megumi
authors.initials: M
authors.lastname: Iwai
authors.forename: Yuta
authors.initials: Y
authors.lastname: Taniuchi
authors.forename: Masataka
authors.initials: M
authors.lastname: Katashima
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Takahashi
mesh_terms: D000818:Animals; D002214:Capsules / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003512:Cyclohexanones / Q000737:chemistry / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D009579:Nitrobenzoates / Q000737:chemistry / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects; D020176:Tyrosinemias / Q000188:drug therapy* / Q000235:genetics
chemical_list: D002214:Capsules; D003512:Cyclohexanones; D004791:Enzyme Inhibitors; D009579:Nitrobenzoates; C077073:nitisinone